A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria:
Fort Lauderdale, Florida 33312, United States
CABA, Buenos Aires C1120AAC, Argentina
CABA, Buenos Aires C1179AAB, Argentina
CABA, Buenos Aires C1180AAX, Argentina
Caba, Buenos Aires C1405BUB, Argentina
CABA, Buenos Aires C1425DES, Argentina
Ciudad Autonoma de Buenos Aire, C1204AAD, Argentina
Krakow, Lesser Poland Voivodeship 31-261, Poland
Ruda Śląska, Silesian Voivodeship 41-709, Poland